Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Zelira Therapeutics.
RELATED STOCKHEAD STORIES
News
ASX Capital Raise Roundup: Low expectations + strong earnings =
Health & Biotech
Weed Week: Amazon scraps marijuana drug tests and Victorian council considers cannabis crops
Health & Biotech
ASX Health Stocks: AnteoTech initiates TGA submission, Zelira jumps 10pc after launching CBD-based acne gel
News
Market Highlights and 5 ASX Small Caps to watch on Thursday
Health & Biotech
ASX Health Stocks: Zelira shares jump on $4m cannabis distribution deal to Germany
News
Market Highlights and 5 ASX Small Caps to watch on Monday
News
Market highlights and 5 ASX small caps to watch on Monday
Health & Biotech
Weed Week: Connecticut and Mexico on board cannabis bandwagon, as Rinehart enters the industry
Health & Biotech
Weed Week: Amazon all-in on marijuana; free joints for jabs and Creso Pharma dual-listed in US
News
Last Orders: ASX gains nearly 1 per cent back from the long weekend
Health & Biotech
Why these 4 ASX cannabis stocks got investors’ attention today
News
Market highlights and 5 ASX small caps to watch on Tuesday
News
Market highlights and 5 ASX small caps to watch on Thursday
News
Market highlights and 5 ASX small caps to watch on Thursday
Health & Biotech
Cann Group lowers guidance, makes acquisition; Zelira to get new boss
Experts
ScoPo’s powerplays: Jazz Pharma’s $9.4b deal highlights pot plays
Health & Biotech
